Skip to main content
  • Infection Risk in Endovascular Neurointerventions – A Comparative Analysis of 279 Cases With and Without Prophylactic Antibiotic Use

    Final Number:
    177

    Authors:
    Jan-Karl Burkhardt MD; Omar Tanweer MD; Miguel Litao; Pankaj Sharma; Eytan Raz; Maksim Shapiro; Peter K. Nelson MD; Howard A. Riina MD, FACS

    Study Design:
    Clinical trial

    Subject Category:
    Aneurysm/Subarachnoid Hemorrhage

    Meeting: AANS/CNS Cerebrovascular Section 2018 Annual Meeting

    Introduction: A systematic analysis on the utility of prophylactic antibiotics for endovascular neurointerventions has not been determined. At our institution we have the unique set-up to address this question with attendings using prophylactic antibiotics (cefazolin or vancomycin) for all neurointervention while others never do.

    Methods: We performed a retrospective review of all neurointerventions at NYU Tisch Hospital (279 cases in 246 patients) between 2015 and 2016. Clinical and radiological data were collected for analysis including presence of prophylactic antibiotic use, local or systemic infection, infection laboratory values and treatment. Out of 279 neurointerventions 151 aneurysms, 72 AVM/AVF, 40 tumors and 16 vessel stenosis/dissections were treated with coiling (n=54), pipeline embolization device (n=97) embolization (n=112) or stenting (n=16), respectively.

    Results: Antibiotic prophylaxis was used in 132 out of 279 cases (47%). There was no significant difference between patients with or without antibiotic prophylaxis in age (p=0.68), gender (p=0.10), presence of multiple interventions (p=0.85), diseases treated (p=0.46) and intervention device placed (p=0.84). Two mild local groin infections (0.4%) and no systemic infections (0%) were identified in this cohort with one case in each group (1/132, 0.8% vs. 1/147, 0.7%). Both patients recovered completely with local drainage (n=1) and antibiotic treatment (n=1).

    Conclusions: The risk of infection associated with endovascular neurointerventions with or without prophylactic antibiotic use was very low in this cohort. The data suggest that the routine use of antibiotic prophylaxis seems unnecessary and should be reserved for selected patient in risk to prevent antibiotic resistance and to reduce costs.

    Patient Care: The data suggest that the routine use of antibiotic prophylaxis seems unnecessary and should be reserved for selected patient in risk to prevent antibiotic resistance and to reduce costs.

    Learning Objectives: By the conclusion of this session, participants should be able to understand the importance of prophylactic antibiotic use in neurointerventions

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy